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Novelty & Impact Statements 
Genome-wide integration of GWAS and lung eQTL reveals candidate target genes for lung 
cancer. These include a new susceptibility locus for lung adenocarcinoma on chromosome 9p13.3 
with AQP3 (aquaporin 3) as the most likely target gene and IREB2 (iron responsive element 
binding protein 2) on chromosome 15q25 for all histological subtypes. Putative causal genes 
acting through expression in lung provide insights about disease etiology and refine the biological 
interpretation of previous GWAS. 
 
Abbreviations 
COPD, chronic obstructive pulmonary disease 
dbGaP, database of Genotypes and Phenotypes 
enet, elastic net regression 
eQTL, expression quantitative trait loci 
FDR, false-discovery rate 
GTEx, Genotype-Tissue Expression 
GWAS, genome-wide association study 
LASSO, least absolute shrinkage and selection operator 
lncRNA, long non-coding RNA 
MHC, major histocompatibility complex 
SCLC, small cell lung cancer 
TRICL-ILCCO, Transdisciplinary Research in Cancer of Lung team of the International Lung 
Cancer Consortium 
TWAS, transcriptome-wide association study 
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We have recently completed the largest GWAS on lung cancer including 29,266 cases and 
56,450 controls of European descent. The goal of this study has been to integrate the complete 
GWAS results with a large-scale expression quantitative trait loci (eQTL) mapping study in 
human lung tissues (n=1,038) to identify candidate causal genes for lung cancer. We performed 
transcriptome-wide association study (TWAS) for lung cancer overall, by histology 
(adenocarcinoma, squamous cell arcinoma, small cell lung cancer) and smoking subgroups 
(never- and ever-smokers). We performed replication analysis using lung data from the 
Genotype-Tissue Expression (GTEx) project. DNA damage assays were performed in human 
lung fibroblasts for selected TWAS genes. As expected, the main TWAS signal for all 
histological subtypes and ever-smokers wason chromosome 15q25. The gene most strongly 
associated with lung cancer at this locus using the TWAS approach was IREB2 (PTWAS=1.09E-
99), where lower predicted expression increased lung cancer risk. A new lung adenocarcinoma 
susceptibility locus was revealed on 9p13.3 and associated with higher predicted expression of 
AQP3 (PTWAS=3.72E-6). Among the 45 previously described lung cancer GWAS loci, we 
mapped candidate target gene for 17 of them. The association AQP3-adenocarcinoma on 9p13.3 
was replicated using GTEx (PTWAS=6.55E-5). Consistent with the effect of risk alleles on gene 
expression levels, IREB2 knockdown and AQP3 overproduction promote endogenous DNA 
damage. These findings indicate g nes whose expression in lung tissue dir ctly influence lung 
cancer risk. 
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Genome-wide association studies (GWAS) to date have reported 45 lung cancer susceptibility 
loci in European and Asian populations1. Identifying the causal genes underpinning these loci 
remains a major challenge. Expression quantitative trait loci (eQTL) in disease relevant tissues 
are known to complement GWAS results by providing the specific genes whose expression levels 
are associated with disease-associated SNPs2. This strategy has been applied in lung cancer by 
directly testing disease-associated SNPs for association with expression levels of nearby genes in 
lung tissues3. 
 
Recent development in bioinformatics now allows transcriptome-wide association study 
(TWAS), which is a more advanced approach to integrate GWAS and eQTL results and identify 
candidate causal genes underlying diseases4, 5. TWAS requires a set of individuals for whom both 
gene expression and genetic variants have been measured, i.e. an eQTL dataset. The part of gene 
expression that can be explained by cis-acting SNPs can then be modeld in the eQTL dataset 
and used to impute the genetic component of expression in a second (usually larger) set of 
individuals with only SNP GWAS data. The approach can be conceptualized as having imputed 
expression data for all cases and controls used in a GWAS without directly measuring expression 
levels in these samples. The association between imputed gene expression and the disease (or 
biological trait) of interest is then evaluated by performing a TWAS. 
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In this study, we combined the largest GWAS on lung cancer6 and the largest lung eQTL study7 
to perform a TWAS on lung cancer, histological subtypes and smoking subgroups. The objective 
is to identify candidate target genes for lung cancer residing within and outside GWAS-
nominated loci.  
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Materials and Methods 
Lung eQTL dataset 
The lung eQTL dataset consists of whole-genome genotyping (Illumina Human1M-Duo 
BeadChip) and gene expression (Affymetrix) in non-tumor lung tissues from patients who 
underwent lung surgery at three academic sites, Laval University, University of British 
Columbia, and University of Groningen, henceforth referred to as Laval, UBC, and Gro ingen, 
respectively. All lung specimens from Laval were obtained from patients undergoing lung cancer 
surgery and were harvested from a site distant from the tumor. At UBC, the majority of samples 
were from patients undergoing resection of small peripheral lung lesions. Additional samples 
were from autopsy and at the time of lung transplantation. At Groningen, the lung specimens 
were obtained at surgery from patients with various lung diseases, including patients undergoing 
therapeutic resection for lung tumors, harvested from a site distant from the tumor, and lung 
transplantation. Lung tissue processing and storage, DNA and RNA extraction, gen typing, 
microarray-based gene expression and lung cis-eQTL analyses have been described previously7, 8. 
Following standard microarray and genotyping quality controls, data on 1,038 patients were 
available. At Laval and UBC, written informed consent was obtained from all subjects and the 
study was approved by their respective ethics committee. At Groningen, lung specimens were 
provided by the local tissue bank of the Department of Pathology and the study protocol was 
consistent with the Research Code of the University Medical Center Groningen a d Dutch 
national ethical and professional guidelines (“Code of conduct; Dutch federation of biomedical 
scientific societies”; http://www.federa.org). 
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The GWAS data were derived from the Transdisciplinary Research in Cancer of Lung team of 
the International Lung Cancer Consortium (TRICL-ILCCO) OncoArray project comprising 
29,266 lung cancer cases and 56,450 controls of European ancestry based on OncoArray and 
other Illumina genome-wide arrays6. The GWAS was performed using logistic regression to 
evaluate the association of genetic variants with overall lung cancer and the predominant 
histological subtypes including adenocarcinoma (n=11,273), squamous cell carcinoma (n=7,426), 
and small cell lung cancer (SCLC) (n=2,664). Genetic variants were also tested for association in 
never- (n=2,355) and ever-smokers (n=23,223). For this study, summary statistics were available 
for more than 10 million genotyped and imputed SNPs for overall lung cancer, histological 
subtypes and smoking subgroups (range 10,333,102 to 11,268,805). All participating studies in 
the TRICL-ILCCO OncoArray project were approved by their local ethics committee and all 
participants signed an informed consent. 
 
Transcriptome-wide association study 
The TWAS was performed for lung cancer overall, histological subtypes, and smoking subgroups 
using two approaches, i.e. S-PrediXcan5 and FUSION4. The lung eQTL dataset was used as the 
training set to derive the expression weights. Gene expression normalized for age, sex and 
smoking status from Laval, UBC, and Groningen were combined with ComBat9. 
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For analysis with S-PrediXcan, gene expression traits were first trained with elastic net linear 
models (alpha=0.5, n_k_folds=10, window=500 Kb) using the lung eQTL set. Models with false-
discovery rate (FDR)<0.05 as implemented in S-PrediXcan were obtained for 19,889 probe sets. 
Predicted expression levels from the lung in the TRICL-ILCCO OncoArray project were then 
tested for association with lung cancer5. 
For analysis with FUSION, expression prediction models for each gene were evaluated in cis, 
using markers within 500 Kb on both sides of the expression probe sets. Probe sets that passed 
QC in the lung eQTL dataset (n=41,738) were evaluated and significant cis-heritability (P<0.01) 
were observed for 12,587 annotated probe sets. The best performing prediction models 
implemented in FUSION were LASSO regression and elastic net regression (enet) for 8,254 and 
4,333 probe sets, respectively. Once the expression weights were obtained, expression imputation 
was performed using the summary statistics from the TRICL-ILCCO OncoArray project. 
For both approaches, genome-wide significant TWAS were considered at PTWAS<0.05 based on 
Bonferroni correction (S-PrediXcan PTWAS=0.05/19,889=2.51E-6; FUSION 
PTWAS=0.05/12,587=3.97E-6). A more liberal significant threshold was also used (PTWAS<0.0001) 
to explore the top TWAS signals not reaching genome-wide significance for some histological or 
smoking subgroups. Finally, the top TWAS genes in previously established lung cancer risk loci 
that showed some evidence of association (PTWAS<0.05) with both S-PrediXcan and FUSION 
were considered. For both TWAS approaches, we reported well-annotated probe sets. 
LocusCompare10 was used to visualize GWAS and eQTL colocalization events. 
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Published GWAS loci for lung cancer 
Lung cancer GWAS loci were derived from our recent review1. The boundaries of each locus 
were defined by adding 1 Mb downstream and upstream of lung cancer-associated SNPs derived 
from published GWAS on lung cancer. The genomic locations of TWAS genes were then 
overlapped with these lung cancer loci to delineate those residing within or outside GWAS loci. 
 
TWAS replication 
Lung eQTL data from 383 individuals available in the Genotype-Tissue Expression (GTEx) 
project (GTEx, version 7)11 were used for TWAS replication. The TWAS was performed using 
S-PrediXcan and FUSION as described above. 
 
In vitro assays 
Cell line, plasmids and reagents. MRC-5V2 (male, SV40-immortalized human lung fibroblasts, 
Research Resource Identifier (RRID): CVCL_2627, source: Stephen P. Jackson Lab) cell line 
was maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Catalog #: 41965) 
supplemented with 10% fetal bovine serum (Gibco, Catalog #: 10438034), 2 mM L-glutamine, 
100たg/mL penicillin, 100 たg/mL and streptomycin as previously described12. The human cell line 
has been authenticated using STR profiling within the last three years and all experiments were 
performed with mycoplasma-free cells. Gateway compatible AQP3 entry clone was obtained 
from ccsbBroad gene libraries (ccsbBroadEn_00089). We subcloned AQP3 into a mammalian 
expression vector containing a GFP epitope tag (pcDNA6.2/N-EmGFP-DEST, Invitrogen), 
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which allows us to separate the transfected and non-transfected cell populations. Overproduction 
plasmids transfections were performed using GenJet (SignaGen, Catalog #: SL100488). 
SMARTpool IREB2 and NEXN siRNAs as well as non-targeting (NT) siRNA were purchased 
from Dharmacon. siRNA transfections were carried out with lipofectamine RNAiMax 
(Invitrogen #13778150) following the manufacturer’s instructions. Knockdown efficiency was 
evaluated by real-time quantitative reverse transcription PCR (qRT-PCR). RNeasy mini kit 
(Qiagen #74106) was used to extract from MRC-5V2 cells that were transfected with siRNA for 
72 hours. 300 ng of total RNA from each sample was used to synthesize cDNA by the 
Superscript III first strand synthesis system (Invitrogen, #18080051). qPCR reactions were 
performed using iTaq Universal SYBR Green Supermix (BioRad #172-5121). qPCR experiments 
were performed on the QuantStudio 3 Real-Time PCR System (Applied Biosystems). For each 
gene, three replicates were analyzed and the average threshold cycle (Ct) was calculted. The 
relative expression levels were calculated with the 2–〉〉Ct method13. Primers used included IREB2 
forward: TCTTGGTATTACAAAGCACCTCAG; IREB2 reverse: 
TCACATTGTCAACAGGGAAAAAG; GADPH forward: CAATGACCCCTTCATTGACC; 
GADPH reverse: GATCTCGCTCCTGGAAGATG; NEXN forward: 
ACTGTGAAGGGTAGATTTGCTG; NEXN reverse: TTCTGCGTTTTCGTTCCTCCT. 
Knockdown efficiency was 88% for IREB2 and 95% for NEXN. 
 
DNA damage assays by flow cytometry. Flow-cytometric DNA damage assays and 
quantification signals were performed as previously described12. Briefly, cells were fixed, 
This article is protected by copyright┻ All rights reserved┻
Bossé et al. 
 
 
permeabilized and stained with けH2AX antibody (Sigma, Catalog #05-636), then samples were 
measured by a BD LSRFortessa flow cytometer and analyzed using FlowJo software. For 
overproduction experiments, cells with mock transfection were used to set the threshold gating to 
determine the percentage of GFP- and けH2AX- cells, with 0.5% of control cells gated as the 
damage threshold as previously validated. The DNA-damage ratio caused by protein
overproduction is defined by (Q2/Q3)/(Q1/Q4), where Q2 is the number of transfected damage-
positive cells; Q3 is the number of transfected damage-negative cells; Q1 is the number of 




The GWAS data set used for the current study is available at the database of Genotypes and 
Phenotypes (dbGaP) under accession phs001273.v1.p1. The human lung tissue eQTL study is 
available in dbGaP under accession phs001745.v1.p1.  
This article is protected by copyright┻ All rights reserved┻




Genes with cis-genetic component of expression in the lung 
A total of 1,038 individuals for whom both gene expression and genetic variants were measured 
(i.e. the lung eQTL dataset) were used to impute the cis genetic component of expression into the 
larger set of 29,266 cases and 56,450 controls from the TRICL-ILCCO OncoArray project using 
their SNP genotype data (i.e. GWAS data). Integration of the lung eQTL and lung cancer GWAS 
was performed by two TWAS approaches, namely S-PrediXcan and FUSION. To be assessed by 
TWAS, a significant portion of gene expression had to be explained by SNPs. For S-PrediXcan, 
expression prediction models were obtained for 19,889 probe sets. On average, SNPs explained 
4.95% of the probe sets expression variance, including 62.2% of probe sets that showed a 
prediction performance (R2) of at least 0.01 (Supplementary Figure 1A). For FUSION, 
significant cis-heritability was observed for 12,587 annotated probe sets. On average, SNPs 
explained 7.39% of the probe sets expression variance, including 80.4% of probe sets for which 
their expression variance is explained by more than 1% (Supplementary Figure 1B). Significant 
cis-heritability was observed for 12,099 probe sets in both S-PrediXcan and FUSION 
(Supplementary Figure 1C) and the expression variance explained by SNPs for these probe sets 
was tightly correlated between the two methods (Supplementary Figure 1D). 
 
Overall lung cancer 
The TWAS results for overall lung cancer are illustrated in Figure 1A. TWAS genes that are 
statistically significant after Bonferroni correction are indicated in Table 1. The top TWAS 
This article is protected by copyright┻ All rights reserved┻
Bossé et al. 
 
 
signal is on chromosome 15q25, which is well-established as the strongest lung cancer 
susceptibility locus derived from GWAS. Interestingly, IREB2 is the lead TWAS target gene on 
15q25 by S-PrediXcan (PTWAS=1.09E-99). Other statistically significant TWAS genes include 
CHRNA3 (PTWAS=4.66E-65), CHRNA5 (PTWAS=6.01E-22), HYKK (PTWAS=6.57E-17), and 
PSMA4 (PTWAS=1.42E-13). In FUSION, IREB2 also has a level of significance stronger 
(PTWAS=4.97E-104) than other significant TWAS genes at this locus including CHRNA5 
(PTWAS=5.26E-20), HYKK (PTWAS=2.04E-17), and PSMA4 (PTWAS=4.15E-13). Lower predicted 
expression of IREB2 is associated with increased lung cancer risk. Figure 2 shows the 
colocalization of the GWAS and lung eQTL signals on 15q25 as well as the effect of the top 
GWAS SNP on the expression of IREB2. LocusCompare plots show the colocalization events for 
IREB2 as well as other significant TWAS genes on 15q25 (Supplementary Figure 2). The lung 
cancer risk allele is associated with lowered expression of IREB2 in lung tissues. 
 
Significant TWAS genes are also identified at two loci on chromosome 6. The most significant, 
and containing the largest number of TWAS genes, is the MHC locus, including 23 significant 
genes (Table 1). The top TWAS gene is APOM in both S-PrediXcan and FUSION. In the MHC 
locus, lower predicted expression of 16 genes and higher predicted expression of 7 genes are 
associated with increased lung cancer risk. The direction of effect is consistent for the six genes 
in common between S-PrediXcan and FUSION (Supplementary Figure 3). The second locus on 
chromosome 6 (6q27) identifies RNASET2 and FGFR1OP as the TWAS gene in S-PrediXcan 
(PTWAS=2.33E-8) and FUSION (PTWAS=7.68E-8), respectively. 
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Significant genes are observed at three additional loci. First, RAD52 on 12p13.33 
(PTWAS=6.58E-10) by S-PrediXcan with higher predicted expression associated with higher lung 
cancer risk. Second, SECISBP2L on 15q21.1 by S-PrediXcan (PTWAS=5.44E-9) and FUSION 
(PTWAS=8.01E-10), which we have recently identified as the candidate target gene6. Third, JAML 
on 11q23.3 by S-PrediXcan (PTWAS=2.64E-7) and FUSION (PTWAS=1.39E-6) with lower 
predicted expression associated with higher lung cancer risk. 
 
Overall, TWAS genes are identified in six lung cancer susceptibility loci previously established 
by GWAS (Table 1). A potentially novel susceptibility gene is identified for 6q27-FGFR1OP. 
For the other five loci, the TWAS results refined putative causal genes suspected by GWAS and 
demonstrated their direction of effects with lung cancer risk. LocusCompare plots for these 
TWAS hits are provided in Supplementary Figure 4. 
 
Histological subtypes 
TWAS results by histological subtypes are shown in Figures 1B-D and Table 1. IREB2 is the top 
TWAS gene for the three predominant subtypes, namely adenocarcinoma, squamous cell 
carcinoma and SCLC. Consistent with overall lung cancer, lower predicted expression i  
associated with increased risk of all histological subtypes. 
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For adenocarcinoma, consistent results between S-PrediXcan and FUSION are observed for 
NRG1 on 8p12 (S-PrediXcan PTWAS=3.29E-8, FUSION PTWAS=1.21E-7) and AQP3 on 9p13.3 (S-
PrediXcan PTWAS=3.72E-6, FUSION PTWAS=3.49E-6). The later is a new lung cancer 
susceptibility locus. Figure 3 and Supplementary Figure 5 show the colocalization of the 
GWAS and lung eQTL signals on 9p13.3 as well as the effect of the top GWAS SNP on the 
expression of AQP3. The lung cancer risk allele is associated with higher expression of AQP3 in 
lung tissues. Additional TWAS genes for adenocarcinoma identified by S-PrediXcan and 
FUSION include SECISBP2L on 15q21.1 (S-PrediXcan PTWAS=1.92E-16 and FUSION 
PTWAS=2.50E-17), TP63 on 3q28 (S-PrediXcan PTWAS=2.50E-11 and FUSION PTWAS=3.35E-12), 
and JAML on 11q23.3 (S-PrediXcan PTWAS=1.21E-8 and FUSION PTWAS=2.09E-8). S-PrediXcan 
identifies DCBLD1 on 6q22.1 (PTWAS=3.59E-7). Lower predicted expression of all these genes 
(DCBLD1, TP63, SECISBP2L, JAML) is associated with increased risk of adenocarcinoma. All 
these loci were associated with lung cancer before. Int restingly, no significant TWAS gene in 
the MHC region was observed for adenocarcinoma. 
 
For squamous cell carcinoma, the MHC region includes many TWAS genes (Figure 1C and 
Table 1). Similar to results observed for overall lung cancer, the top TWAS gene using S-
PrediXcan and FUSION is APOM. There is one additional TWAS gene for squamous cell 
carcinoma by S-PrediXcan on 12p13.33. The target gene is RAD52 (PTWAS=1.24E-10) and the 
direction of effect indicates that higher expression is associated with an i creased risk of 
squamous cell carcinoma. In FUSION, one more TWAS gene is identified for squamous cell 
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carcinoma, namely BLOC1S2 (PTWAS=2.16E-6) on 10q24.31 with lower predicted expression 
associated with squamous cell carcinoma. BLOC1S2 is a new candidate causal gene for 
squamous cell carcinoma. 
 
For SCLC, the only significant TWAS gene other than IREB2 and CHRNA3 on 15q25 was 
HIST1H2BD on 6p22.2 (MHC locus) by FUSION (PTWAS=1.54E-6) with predicted expression 
positively associated with SCLC. A second TWAS gene that just missed genome-wide 
significance is TMA16 (PTWAS=4.2E-6) on 4q32.2, which is a locus not yet reported for lung 
cancer. Higher predicted expression of TMA16 is associated with higher risk of SCLC. S-
PrediXcan did not provide a significant gene expression model for TMA16. 
 
Smoking subgroups 
TWAS results for ever- and never-smokers are in Figures 1E-F and Table 1. The TWAS in ever-
smokers parallel results observed for overall lung cancer, albeit at lower significance levels. This 
includes IREB2, CHRNA3, and CHRNA5 on 15q25, SECISBP2L on 15q21.1, RAD52 on 
12p13.33 by S-PrediXcan, and many genes in the MHC locus. The direction of effects is also 
consistent with overall lung cancer. For never-smokers, no TWAS gene reach genome-wide 
significance. One gene is identified using a more liberal significant hreshold (PTWAS<0.0001) 
using both TWAS approaches, namely NEXN on 1p31.1 with predict expression negatively 
associated with lung cancer in never-smokers. Figure 4 shows the GWAS results for never-
smokers on 1p31.1 and lung eQTL signals for NEXN. Colocalization events can further be 
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visualized in Supplementary Figure 6. The lung cancer risk allele is associated with lower 
expression of NEXN in lung tissues. NEXN has never been reported as a lung cancer 
susceptibility gene. 
 
Lung cancer risk loci from GWAS 
We also explored the top TWAS genes in known lung cancer risk loci derived from previous 
GWASs. The boundaries of each locus were defined (see methods) and the top TWAS genes by 
S-PrediXcan and FUSION for overall lung cancer are indicated in Table 2. The top TWAS gene 
(PTWAS<0.05) is consistent for both S-PrediXcan and FUSION at 6 additional loci (not in Table 
1): ORMDL1 on 2q32.2, SLC22A5 on 5q31, TRIM38 on 6p22.2, MTAP on 9p21.3, N4BP2L2 on 
13q13.1, and MTMR3 on 22q12.2. Colocalization of GWAS and lung eQTL signals supports 
ORMDL1, SLC22A5, and TRIM38 as candidate causal genes at these loci (Supplementary 
Figure 7). In contrast, the strongest lung eQTL variants for MTAP, N4BP2L2, and MTMR3 have 
weak GWAS p values (Supplementary Figure 7), suggesting the possibility of false-positive 
TWAS genes and the need to use alternative approaches to find the causal genes at ths  loci.
Overall, we map candidate causal genes for 17 out of the 45 known lung cancer GWAS loci. 
Supplementary Figure 8 summarizes candidate target genes for lung cancer identified in this 
study residing within and outside GWAS-nominated loci. 
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Replication in GTEx 
The lung eQTL data from 383 individuals available in GTEx was used to validate the results. We 
first evaluated the new adenocarcinoma locus on 9p13.3-AQP3. The association AQP3-
adenocarcinoma is strongly validated in GTEx (S-PrediXcan PTWAS=6.55E-5 and FUSION 
PTWAS=1.72E-5) with a consistent direction of effect, i.e. the risk allele increases the expression 
levels of AQP3 in lung tissues. Second, we assessed NEXN as the new target gene underlying the 
1p31.1 locus in never-smokers. The association and direction of effect were replicated (S-
PrediXcan PTWAS=0.006 and FUSION PTWAS=0.003) with predicted expression negatively 
associated with lung cancer in never-smokers. 
 
We also compared candidate target genes identified in GWAS-nominated loci. Note that 
replication of S-PrediXcan and FUSION results in GTEx lung data is only feasible for genes with 
significant prediction models. The sample size available for building lung models in GTEx is 
smaller (n=383) compared to our lung eQTL dataset (n=1,038). Therefore, replication is not 
feasible for a fraction of genes in GTEx lung, i.e. some genes will have no significant prediction 
model. This is the case for IREB2 on 15q25 that did not yield a prediction model in GTEx lung. 
The top TWAS gene on 15q25 for overall lung cancer in GTEx lung is CHRNA5 (PTWAS=1.70E-
14). Replication of all Bonferroni-corrected TWAS genes by histology and smoking subgroups is 
indicated in Table 1. Excluding the 15q25 and 6p-MHC loci, replication of TWAS genes was 
observed for 3 out of 4 for overall lung cancer, 6 out of 6 for adenocarcinoma, 2 out of 2 for 
squamous cell carcinoma, 1 out of 1 for SCLC, 2 out of 2 for ever-smokers, and 1 out of 1 for 
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never-smokers. Among the 6 additional loci showing the same top TWAS gene for both S-
PrediXcan and FUSION, 4 could be evaluated in GTEx and 3 were replicated: 5q31-SLC22A5, 
9p21.3-MTAP and 22q12.2-MTMR3 (Table 2). Overall, for the 17 TWAS genes located in the 45 
GWAS-nominated loci, 14 could be evaluated in GTEx and 12 were replicated. 
 
Endogenous DNA damage assays 
We hypothesized that some of the TWAS-nominated genes might promote cancer by increasing 
endogenous DNA damage, and subsequently lead to genome instability. Three TWAS genes 
were selected for in vitro assays: IREB2 on 15q25, AQP3 on 9p13.3, and NEXN on 1p31.1. The 
choice between knockdown and overproduction assays was guided by the direction of effect
observed in the TWAS. For IREB2 and NEXN, knockdown assays were performed to corroborate 
lower predicted expression associate with increased lung cancer risk, whereas overproduction 
assays were performed for AQP3 to mimic higher predicted expression ass ciate with increased 
risk of lung cancer. We discovered that knockdown of IREB2 increased endogenous DNA 
damage in human lung fibroblasts (Figure 5). In contrast, knockdown of NEXN had no effect on 
DNA damage. For AQP3, overproduction promotes endogenous DNA damage in lung fibroblasts 
(Figure 5). 
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This study is the largest lung tissue based TWAS on lung cancer; gene expression prediction 
models built with a lung eQTL dataset of 1,038 individuals and association analyses of predicted 
gene expression with lung cancer risk using summary statistics derived from a GWAS on 29,266 
cases and 56,450 controls. We revealed a new lung adenocarcinoma locus on 9p13.3 associated 
with the expression levels of AQP3 in lung tissues. We also identified candidate causal genes at 
GWAS-nominated lung cancer loci including IREB2 on 15q25 for all histological subtypes. 
Cellular DNA damage assays further supported the potential causality of lower predicted 
expression of IREB2 and higher predicted expression of AQP3 in increasing the risk of lung 
cancer. Overall, we map putative causal genes for 17 out of the 45 known lung cancer risk loci 
derived from GWAS. 
 
During the last 10 years, GWAS have identified 45 susceptibility loci for lung cancer1. The genes 
underlying these genetic associations are largely unknown. As with other complex diseases, the 
GWAS risk variants for lung cancer are mostly located in non-coding regions and are thus 
believed to mediate their effects by influencing gene expression of nearby genes. In this study, 
we used a TWAS approach that captures th  aggregate effects of multiple SNPs on gene 
expression and then tested the association of genetically predicted gene expression and disease 
risk. As a gene-based strategy, TWAS has the ability to identify the most likely target genes 
residing within GWAS-nominated loci, and also to reveal novel risk loci by the resulting power 
of combining GWAS and eQTL results. In this study, TWAS was performed using two 
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competing approaches, i.e. S-PrediXcan and FUSION. Both belong to the same family o  
methods to discover gene-trait associations using models trained in eQTL datasets and summary-
level GWAS data. The difference lies in the prediction models, i.e. S-PrediXcan uses elastic net 
(enet), while FUSION evaluates different prediction schemes (herein: enet, LASSO, top1) and 
selects the best performing model. Using default parameters, we obtained more expression 
prediction models in S-PrediXcan compared to FUSION (19,889 vs. 12,587 probe sets with 
significant cis-heritability). However, the prediction performance of the 12,099 probe sets in 
common between S-PrediXcan and FUSION were tightly correlated, even when different 
prediction models (enet vs LASSO) were used (Supplementary Figure 1D). 
 
The majority of TWAS genes identified in this study lie around known GWAS loci. The only 
SNP-level sub-genome-wide significant locus that yield genome-wide significant results by 
TWAS is 9p13.3-AQP3 for adenocarcinoma. This novel susceptibility locus for adenocarcinoma 
(9p13.3-AQP3) was observed in S-PrediXcan and FUSION, and was also replicated in GTEx 
lung (Table 1). The direction of effect indicates that higher AQP3 expression is associated with 
an increased risk of lung adenocarcinoma. AQP3 (aquaporin 3) encodes a water channel protein 
that is expressed in the normal respiratory track and up-regulated in NSCLC, especially 
adenocarcinoma14, 15. Knockdown of AQP3 has been shown to suppress proliferation and 
invasion of lung cancer cells16, 17 as well as to inhibit tumor growth in human NSCLC 
xenografts18. The direction of effect observed in our study is thus concordant with these 
functional studies. In the current study, we further demonstrated that AQP3 overproduction 
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promotes endogenous DNA damage in human lung fibroblasts. All together these observations 
support AQP3 as the causal gene for lung adenocarcinoma on 9p13.3. The genetic association 
between AQP3 and lung adenocarcinoma will require further validation. 
 
Novel susceptibility genes were identified in previously established GWAS loci. In never-
smokers, we have identified NEXN (nexilin F-actin binding protein) as the putative causal gene 
on 1p31.1. Nexilin is an actin-binding protein known to play a role in cell adhesion and 
migration. Mutations in this gene have been associated with cardiomyopathy19, 20. The 1p31.1 
locus was first demonstrated to be associated with lung cancer as part of a genome-wide 
investigation of SNPs within all long non-coding RNA (lncRNA) genes21. SNP rs114020893 
located in lncRNA NEXN-AS1 was associated with lung cancer and with similar association 
between adenocarcinoma and squamous cell carcinoma subgroups. In silico analysis then 
predicted that rs114020893 could change the folding structure of NEXN-AS1. However, it was 
unclear if the lung cancer-associated SNP was acting through NEXN-AS1 or by regulating the 
expression of its corresponding gene, NEXN. Our current study supports the later. In this lncRNA 
study21, analyses by smoking subgroups were not performed. In McKay et al.6, the 1p31.1 locus 
was GWAS significant for overall lung cancer as well asfor adenocarcinoma and ever-smoker 
subgroups, but did not reach significance in never-smokers. By using a TWAS approach, we 
demonstrated that this locus might also be relevant for the development of lung cancer in never-
smokers and, at least in this subgroup, the susceptibility locus may mediate its effect by down-
regulating the expression of NEXN in lung tissues. Interestingly, a recent study demonstrated that 
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the expression levels of NEXN-AS1 and NEXN are decreased in human atherosclerotic plaques 
and NEXN deficiency promotes atherosclerosis in an experimental mouse model22. NEXN seems 
to confer protection against atherosclerosis by suppressing inflammatory cyt kines (IL-6 and 
TNFg), adhesion molecules (ICAM1, VCAM1, and MCP1), and extracellular matrix degrading 
enzymes (MMP1 and MMP9). The control exerted by NEXN on these molecular processes may 
also come into play in lung cancer. Here we showed that NEXN knockdown lung fibroblasts do 
not show altered endogenous DNA damage, implying the need of investigating alternative 
mechanisms of action infuture functional studies. 
 
15q25 is the locus most strongly associated with lung cancer1, but also a leading susceptibility 
locus for smoking behavior23 and other traits related to lung disease such as chronic obstructive 
pulmonary disease (COPD)24. COPD and lung cancer-associated variants in 15q25 are known 
expression and methylation QTL (eQTL and meQTL) for multiple genes and tissues3, 25. It has 
not been possible so far to definitely identify all of the causal gene(s) at this locus, but most 
evidence points toward CHRNA5 (cholinergic receptor nicotinic alpha 5 subunit) or IREB2 (iron 
responsive element binding protein 2). In this study, we focused specifically on gene expression 
in lung tissues with the hope to identify genes directly involved in lung cancer development. 
More than one Bonferroni-corrected TWAS genes were identified at 15q25. The top one was 
IREB2, and then in order of significance, CHRNA3, CHRNA5, HYKK, and PSMA4. IREB2 was 
also the top significant TWAS gene at this locus for COPD8, and the results is in line with 
previous analysis specifically focused on 15q2526. IREB2 encodes a RNA-binding protein that 
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regulates iron levels in cells. Alteration of iron metabolism has been observed in NSCLC27 and 
iron has been shown to influence apoptosis of lung cancer cells (A549)28. Silencing of IREB2 in 
these cells has been shown to modulate the expression of iron metabolism-related genes 
(transferrin receptor and ferritin)29 and injection of wild-type IREB2 in mice was shown to 
stimulate growth of tumor xenografts30. Previous studies have thus demonstrated a potential 
biological link between IREB2 and lung cancer. In the current study, knockdown of IREB2 was 
showed to increase endogenous DNA damage in human lung fibroblasts, supporting a potential
cancer-promoting role in the lung by elevated DNA damage and genomic instability. However, 
the 15q25 locus harbors additional candidate genes including three nicotinic receptors, namely 
CHRNA3, CHRNA5, and CHRNB4. Variation in these genes have been strongly associated with 
smoking behavior and other aspects of addiction, thus indirectly affecting lung cancerrisk 
through modulation of smoking behavior31. It should be emphasized that our study is relevant for 
lung expression only and that causal genes of addiction to smoking on 15q25 may be 
complemented by future brain eQTL studies. Similarly, other forms of genetic variation may be 
modulating function at this locus, for example one most associated SNPs at this locus encodes a 
missense change in CHRNA5 (rs16969968). Our results nevertheless suggest the possibility that 
one or more genes acting in the lung, brain or other tissues may mediate the risk of lung cancer 
on 15q25. The IREB2 locus shows linkage disequilibrium with the CHRNA3/CHRNA5/CHRNB4 
locus complicating our ability to distinguish between these genetic effects. Clearly, more research 
will be needed to pinpoint the causal gene(s) or pathway(s) underpinning this lung cancer 
susceptibility locus. 
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On 6p22-p21 (MHC locus), multiple candidate causal genes were identified for overall lung 
cancer, squamous cell carcinoma and ever-smokers. However, no TWAS gene was found for 
adenocarcinoma, which is consistent with previous GWAS showing stronger association with 
squamous cell carcinoma at the MHC locus6, 32. The interpretation of TWAS results in the MHC 
locus is complicated by the extended LD structure in this region. TWAS cannot distinguish 
causal relationship and pleiotropy. For example, if the same SNPs affect the xpression level of 
more than one gene, TWAS cannot delineate the causal one. Here, we id ntified multiple 
candidate genes on 6p22-p21 that varied by histological subtypes and that showed some 
similarity, but also differences between S-PrediXcan and FUSION. Although the top TWAS gene 
with both TWAS approaches was APOM, our study does not provide firm conclusion about the 
most likely causal gene(s) in the MHC locus and suggests the need of using alternative methods 
to reach this goal in this region. 
 
It should be emphasized that TWAS genes do not imply causality. TWAS genes are more 
appropriately interpreted as prioritized or ranked candidate causal genes at loci33. In addition, 
TWAS cannot distinguish causal relationship and pleiotropy. For example, if the same SNPs 
affect the expression level of more than one gene, TWAS cannot delineate the causal one. In this 
study, we intentionally highlighted the top TWAS finding at each locus. It is not uncommon to 
observe multiple TWAS genes per locus, which is caused by co-regulation and shared eQTL34. 
Further functional experiments will be needed to demonstrate causality of oner more genes at 
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each locus. One of the main limitation of TWAS is to study only genes with a significant cis-
heritability, i.e. genes for which a part of expression can be explained by SNPs. This leaves out a 
large proportion of genes including known and potential cancer genes, particularly variants that 
influence gene product function through other ways. On the other hand, by focusing on the 
genetic component of expression, we avoid confounding effects of other factors (measured or 
not) on gene expression. This however does not preclude confounders of the SNP-expression 
correlation derived from the lung eQTL mapping study. We have used bulk gene expression data 
from the lung in both the discovery and validation (GTEx) sets. The lung is a heterogeneous 
tissue containing many cell types (organ-specific and migratory) with relative proportions that 
can vary based on the underlying lung disease, harvesting location, histological subtype , and 
environmental factors35. These factors may have limited our ability to derive lung eQTL signals 
and subsequently study b  TWAS the association between the cis-genetic component of 
expression and lung cancer. In addition, with our approach, we were unable to identify cell type-
specific eQTL signals including from rare (or less frequent) cell types that may give rise to 
cancer that are not well represented in bulk expression data. 
 
In conclusion, this work outlines a new lung adenocarcinoma locus on 9p13.3 with AQP3 as the 
most likely underlying causal gene. Within known lung cancer GWAS loci, we map IREB2 on 
15q25 for all histological subtypes and ever-smokers, NEXN on 1p31.1 in never-smokers, and 
provide putative causal genes for 15 additional loci. The cancer-promoting role of IREB2 and 
AQP3 were further supported by endogenous DNA damage assays in human lung fibroblasts. 
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TWAS genes are key to understand disease etiology, facilitate biological interpretation of GWAS 
results, and prioritize follow-up functional studies. 
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Table 1. TWAS genes identified by lung cancer and smoking subgroups 
Subgroups Loci Bonferroni-corrected TWAS 
genes1 
 GTEx  
  S-PrediXcan (direction) FUSION (direction) S-PrediXcan (direction, 
PTWAS) 
FUSION (direction, PTWAS) 
Overall lung cancer 15q25 IREB2 (-) > CHRNA3 (-) > 
CHRNA5 (-) > HYKK (-) > 
PSMA4 (+) 
IREB2 (-) > CHRNA5 (-) > 
HYKK (-) > PSMA4 (+) 
IREB2 (no model) 
CHRNA3 (-, 1.33E-12) 
CHRNA5 (-, 1.70E-14) 
HYKK (no model) 
PSMA4 (no model) 
IREB2 (no model) 
CHRNA3 (-, 3.54E-23) 
CHRNA5 (-, 1.71E-14) 
HYKK (no model) 
PSMA4 (no model) 
 12p13.33 RAD52 (+)  RAD52 (+, 2.10E-9) RAD52 (+, 1.43E-09) 
 15q21.1 CTSH (+) > SECISBP2L (-) SECISBP2L (-) CTSH (+, 0.00015) 
SECISBP2L (-, 5.79E-8) 
CTSH (+, 0.0001) 
SECISBP2L (-, 4.42E-08) 
 6p-MHC APOM (-) > ZFP57 (+) > HLA-
A (-) > TRIM38 (-) > HLA-F 
(+) > ZKSCAN3 (-) > HLA-
DPB1 (-) > BAT1 (-) > HLA-
DPA1 (+) 
APOM (-) > ZNRD1 (-) > 
PRRC2A (-) > ZFP57 (+) > 
FLOT1 (+) > NOTCH4 (-) > 
TUBB (+) > HLA-A (-) > HLA-
F (+) > HLA-G (-) > HCG8 (-) 
> HLA-J (-) > TRIM38 (-) > 
HCP5 (-) > SFTA2 (+) > HLA-
L (-) > HLA-DQB1 (-) > 
ZKSCAN3 (-) > PSORS1C3 (-) 
> CCHCR1 (+) 
CCHCR1 (+, 5.08E-16)2 FLOT1 (+, 6.05E-16)2 
 6q27 RNASET2 (+) FGFR1OP (-) RNASET2 (+, 1.16E-6) 
FGFR1OP (no model) 
RNASET2 (+, 1.33E-07) 
FGFR1OP (-, 6.23E-04) 
 11q23.3 AMICA1/JAML (-) JAML (-) JAML (no model) JAML (no model) 
Adenocarcinoma 15q25 IREB2 (-) > CHRNA3 (-) > 
CHRNA5 (-) > HYKK (-) 
IREB2 (-) > CHRNA5 (-) > 
HYKK (-) > PSMA4 (+) 
IREB2 (no model) 
CHRNA3 (-, 1.96E-07) 
CHRNA5 (-, 1.23E-8) 
HYKK (no model)  
PSMA4 (no model) 
IREB2 (no model) 
CHRNA3 (-, 1.87E-12) 
CHRNA5 (-, 7.16E-09) 
HYKK (no model) 
PSMA4 (no model) 
 15q21.1 SECISBP2L (-) > GALK2 (+) SECISBP2L (-) > GALK2 (+) > 
FAM227B (-) 
SECISBP2L (-, 2.57E-14) 
GALK2 (no model) 
FAM227B (+, 1.13E-7) 
SECISBP2L (-, 1.54E-14) 
GALK2 (no model) 
FAM227B (+, 8.53E-05) 
 3q28 TP63 (-) TP63 (-) TP63 (-, 3.64E-6) TP63 (no model) 
 11q23.3 JAML (-) JAML (-) JAML (-, 0.158) JAML (no model) 
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 8p12 NRG1 (-) NRG1 (-) NRG1 (-, 2.67E-6) NRG1 (no model) 
 9p13.3 AQP3 (+, PTWAS=3.72E-6) AQP3 (+) AQP3 (+, 6.55E-5) AQP3 (+, 1.72E-05) 
 6q22.1 DCBLD1 (-)  DCBLD1 (-, 8.69E-7) DCBLD1 (-, 4.63E-07) 
Squamous cell 15q25 IREB2 (-)> CHRNA3 (-) > 
CHRNA5 (-) 
IREB2 (-) IREB2 (no model) 
CHRNA3 (-, 0.00095) 
CHRNA5 (-, 0.00063) 
IREB2 (no model) 
CHRNA3 (-, 4.40E-07) 
CHRNA5 (-, 6.78E-04) 
 6p-MHC APOM (-) > HLA-DQB1 (-) > 
TRIM38 (-) > ZKSCAN3 (-) > 
HLA-DPB1 (-) > HLA-DQB2 (-
) > ZNF389 (-) > ZNF187 (-) 
HLA-A (-) > ZFP57 (+) > 
HIST1H2AA (-) > LST1 (+) 
APOM (-) > NOTCH4 (-) > 
PRRC2A (-) > HCP5 (-) > 
HLA-DQB1 (-) > FLOT1 (+) > 
ZNRD1 (-) > MICB (+) > 
TRIM38 (-) > TUBB (+) > 
HLA-A (-) > ZKSCAN3 (-) > 
HCG8 (-) > ZNF192P1 (-) > 
ZSCAN26 (-) > HLA-L (-) > 
ZFP57 (+) > HLA-F (+) > 
HCG14 (+) 
ATF6B (+, 3.70E-15)2 C4A (-, 7.52E-15)2 
 10q24.31  BLOC1S2 (-) BLOC1S2 (-, 4.99E-7) BLOC1S2 (-, 8.36E-07) 
 12p13.33 RAD52 (+)  RAD52 (+, 1.22E-10) RAD52 (+, 5.53E-12) 
SCLC 15q25 IREB2 (-) > CHRNA3 (-) IREB2 (-) IREB2 (no model) 
CHRNA3 (-, 0.023) 
IREB2 (no model) 
CHRNA3 (-, 3.51E-05) 
 6p-MHC  HIST1H2BD (+) HIST1H2BD (no model) HIST1H2BD (no model) 
 4q32.2  TMA16 (+, PTWAS=4.20E-6) TMA16 (no model) TMA16 (-, 9.38E-04) 
Ever-smokers 15q25 IREB2 (-) > CHRNA3 (-) > 
CHRNA5 (-) > HYKK (-) > 
PSMA4 (+) 
IREB2 (-) > CHRNA5 (-) > 
HYKK (-) > PSMA4 (+) 
IREB2 (no model)  
CHRNA3 (-, 9.19E-12) 
CHRNA5 (-, 1.36E-13) 
HYKK (no model) 
PSMA4 (no model) 
IREB2 (no model) 
CHRNA3 (-, 3.47E-20) 
CHRNA5 (-, 4.55E-13) 
HYKK (no model) 
PSMA4 (no model) 
 6p-MHC APOM (-) > ZFP57 (+) > 
TRIM38 (-) > BAT1 (-) > HLA-
A (-) 
APOM (-) > ZNRD1 (-) > 
PRRC2A (-) > ZFP57 (+) > 
NOTCH4 (-) > HLA-G (-) > 
TUBB (+) > HLA-F (+) > 
HCP5 (-) > HLA-J (-) > HLA-A 
(-) > FLOT1 (+) > HLA-DQB1 
(-) > CCHCR1 (+) 
CCHCR1 (+, 5.51E-15)2 FLOT1 (+, 1.38E-14)2 
 15q21.1 SECISBP2L (-) SECISBP2L (-) SECISBP2L (-, 8.73E-7) SECISBP2L (-, 9.70E-7) 
 12p13.33 RAD52 (+)  RAD52 (+, 1.06E-9) RAD52 (+, 2.23E-09) 
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Never-smokers 1p31.1 NEXN (-, PTWAS=3.11E-6) NEXN (-, PTWAS=2.64E-5) NEXN (-, 0.0059) NEXN (-, 0.0028) 
Bold indicates new loci or new susceptibility genes. Novel loci are defined as not overlapping (±500 Kb) with a previously reported 
GWAS lung cancer locus1. 
(+) and (-) indicate predicted gene expression positively or negatively associated with lung cancer risk. 
1Specific PTWAS values are provided for genes that did not pass the Bonferroni significance threshold. 
2Only the top TWAS gene is indicated for the MHC locus. 
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Table 2. Top TWAS genes in GWAS-nominated loci for overall lung cancer 
  








GWAS loci Suspected causal genes by GWAS alone* S-PrediXcan FUSION S-PrediXcan FUSION 







1p31.1 FUBP, DNAJB4 GIPC2 (+, 0.209) 
PIGK (-, 
0.037) 






PIGK (-, 0.2) 









2p16.3 NRXN1     












HIBCH, INPP1, PMS1, 








No genes. Deletions associated 
with cancer 














3q29 C3orf21 CPN2 (+, 0.122)  No model No model 


























































BAG6, APOM, TNXB, MSH5, 
BTNL2, PRRC2A, FKBPL, 
HSPA1B, FOXP4, FOXP4-AS1, 
GTF2H4, LRFN2, HLA-A, 
HLA-DQB1 
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7p15.3 SP4, DNAH11 FAM126A (-, 0.207)  No model No model 




















10p14 GATA3 GATA3 (-,0.633)  No model  






















MPZL3, JAML (also known as 
AMICA1) 


















































































CHRNA5, CHRNA3, CHRNB4, 
IREB2, PSMA4, HYKK 











FAM38B (also known as 
FAM38B2), APCDD1, NAPG 
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20q13.33 RTEL1 RTEL1 (+, 0.007)  No model No model 
















In bold are genes not in Table 1 showing some evidence of association (PTWAS<0.05) with both 
S-PrediXcan and FUSION. 
(+) and (-) indicate predicted gene expression positively or negatively associated with lung cancer 
risk. 
*References are provided in Bossé and Amos1. 
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Figure 1. TWAS results for lung cancer overall, histological subtypes and smoking subgroups. 
Manhattan plots for S-PrediXcan (top) and FUSION (bottom) are illustrated in a mirror view to 
show similarity and differences between the two TWAS approaches. Each point reresents a 
probe set with physical position plotted on the x-axis. The P values for gene expression-lung 
cancer associations are on the y-axis in -log10 scale. Annotations for the significant probe sets 
are indicated. 
A) Overall lung cancer. 
B) Adenocarcinoma. 
C) Squamous cell carcinoma. 





Figure 2. IREB2 is the top candidate target gene on 15q25. The upper left panel shows the 
genetic associations with overall lung cancer in TRICL-ILCCO OncoArray. The bottom left 
panel shows the lung eQTL statistics for IREB2. The location of genes is illustrated at the bottom. 
The right panel shows boxplots of gene expression levels in the lung according to genotype 
groups for Laval, Groningen, and UBC samples. The y-axis shows the mRNA expression levels. 
The x-axis shows the three genotype groups for the SNP most strongly associated with lung 
cancer (upper right) and the SNP most strongly associated with mRNA expression of IREB2 
(lower right) with the number of individuals in parenthesis. The risk allele in TRICL-ILCCO 
OncoArray is shown in red. 
 
 
Figure 3. A novel susceptibility locus for adenocarcinoma on 9p13.3 with AQP3 as the 
underlying gene. The upper left panel shows the genetic associations with adenocarcinoma in 
TRICL-ILCCO OncoArray. The bottom left panel shows the lung eQTL statistics for AQP3. The 
location of genes is illustrated at the bottom. The right panel shows boxplots of gene expression 
levels in the lung according to genotype groups for Laval, Groningen, and UBC samples. The y-
axis shows the mRNA expression levels. The x-axis shows the three genotype groups for the SNP 
most strongly associated with lung cancer (upper right) and the SNP most strongly associated 
with mRNA expression of AQP3 (lower right) with the number of individuals in parenthesis. The 
risk allele in TRICL-ILCCO OncoArray is shown in red. 
 
 
Figure 4. NEXN is the candidate target gene underpinning the lung cancer susceptibility locus for 
never-smokers on 1p31.1. The upper left panel shows the genetic associations with lung cancer in 
never-smokers in TRICL-ILCCO OncoArray. The bottom left panel shows the lung eQTL 
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statistics for NEXN. The location of genes is illustrated at the bottom. The right panel shows 
boxplots of gene expression levels in the lung according to genotype groups for Laval, 
Groningen, and UBC samples. The y-axis shows the mRNA expression levels. The x-axis shows 
the three genotype groups for the SNP most strongly associated with lung cancer (upper right) 
and the SNP most strongly associated with mRNA expression of NEXN (lower right) with the 




Figure 5. IREB2 knockdown and AQP3 overproduction promote endogenous DNA damage. (A) 
Knocking down IREB2, but not NEXN by siRNA causes increased けH2AX level in MRC-5V2 
cell line. Upper: scheme for a siRNA DNA damage assay. Lower left, representativ  flow 
cytometric histogram showing increased けH2AX in cells with IREB2 knockdown compared with 
cells that were transfected with non-targeting siRNA. Lower right, a summary of at least three 
independent experiments for both IREB2 and NEXN, n>20. Mean fluorescence intensity of each 
knockdown experiment was normalized to its corresponding non-targeting siRNA control. Error 
bar: SEM. (B) AQP3 overproduction increases endogenous けH2AX levels in MRC-5V2. Upper: 
full -length sequence-verified AQP3 fused with N-terminal GFP fusion (and GFP-Tubulin as a 
control) were transiently overproduced in MRC-5V2 cell line and the DNA damage levels for 
both non-green and green cells were quantified by flow cytometry (details see methods). Lower 
left: representative flow cytometric histograms of GFP-AQP3, GFP-Tubulin, and mock 
transfection. Lower right: summary, mean ± SEM, n ≥8. 
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